Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study).
The Journal of dermatological treatment（2023）
摘要
This 24-month observational cohort study confirmed that ixekizumab is effective in the long-term management of patients with moderate-to-severe plaque psoriasis.
更多查看译文
关键词
psoriasis,italian retrospective cohort study,retrospective cohort study,long-term,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要